Zaldos Syrup (Erdosteine)

Adult dose

As a 3.5% erdosteine suspension Adults weighing 30 ㎏ or more: Administer 350 mg orally twice daily.

Child dose

Body weight 15～19 ㎏: Administer 175 mg orally twice daily. Body weight 20～30 ㎏: Administer 175 mg orally 3 times daily. Children weighing 30 ㎏ or more: Administer 350 mg orally twice daily.

This medication should not be used by individuals who are allergic to this medication or any of its ingredients. Those with liver cirrhosis or specific enzyme deficiencies should avoid taking this medication due to potential metabolic problems. Patients with peptic ulcers should also be cautious, as it may exacerbate symptoms. Individuals with significantly impaired kidney function should refrain from using this medication for safety. Patients with severely compromised liver function may also face risks when taking this medication. This medication contains lactose, so those with lactose intolerance or related genetic disorders should not take it. Additionally, the artificial sweetener aspartame contained in this medication is broken down into phenylalanine, so individuals with phenylketonuria should avoid it. Patients with mildly impaired liver function must regulate their intake to not exceed 300 mg per day and should take it cautiously. Diabetics or those on a low-calorie diet need to exercise particular caution when using this syrup formulation. In cases of overdose, symptoms such as increased sweating, dizziness, and facial flushing may occur. Neurological and respiratory system adverse reactions like headache, cold symptoms, and difficulty breathing may be reported. Gastrointestinal symptoms including nausea, vomiting, diarrhea, and abdominal pain have also been reported. Skin reactions such as rashes, hives, and eczema may occur. Additionally, fatigue, indigestion, palpitations, facial or systemic swelling, and itching have been reported, although a direct correlation with this medication is not guaranteed. This medication should be used with caution as taking it in conjunction with expectorants may hinder the elimination of phlegm from the bronchial tubes, increasing the risk of bronchial infections. Women who are pregnant or may become pregnant, as well as breastfeeding women, should refrain from taking this medication. This medication should be stored out of the reach of children, and care should be taken to avoid transferring it to other containers as this could lead to accidental ingestion or a decrease in drug quality.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• dysgeusia
• nausea
• vomiting
• diarrhea

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help to safely preserve the effectiveness of the medication for an extended period.

Appearance

This medication is a syrup formulation, a white crystalline powder with a strawberry flavor and taste that is suspended in water. When dissolved in water, it appears as a suspension that is white to light yellow.

Package unit

10 bottles/box [25 grams (50 mL when solvent is added)/bottle X 10]